Extraneous
发表于 2025-3-21 17:44:58
书目名称Dyslipidemias in Kidney Disease影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0284375<br><br> <br><br>书目名称Dyslipidemias in Kidney Disease读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0284375<br><br> <br><br>
Minutes
发表于 2025-3-21 23:34:06
http://reply.papertrans.cn/29/2844/284375/284375_2.png
急急忙忙
发表于 2025-3-22 00:55:14
d by leaders in the field.Includes supplementary material: .Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney d
refine
发表于 2025-3-22 05:52:58
http://reply.papertrans.cn/29/2844/284375/284375_4.png
接触
发表于 2025-3-22 09:19:25
Book 2014lines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. .Dyslipidemias in Kidney Disease .captures the growing body of information on this subject matter. This book presents th
斜坡
发表于 2025-3-22 15:10:13
degradation, and clearance. This chapter examines the lipid profile, underlying pathophysiological mechanism, and treatment of the dyslipidemia observed in patients with nephrotic syndrome, CKD, and diabetic nephropathy.
斜坡
发表于 2025-3-22 19:38:09
https://doi.org/10.1007/978-1-4614-3903-5ts among elderly patients with kidney dysfunction seem to have a benefit, but the data remain limited. Moreover, it should always be considered that elderly patients with chronic kidney disease are at greater risk of adverse drug reactions; therefore, the lowest possible dose of medications should be used.
女歌星
发表于 2025-3-22 23:13:39
http://reply.papertrans.cn/29/2844/284375/284375_8.png
北极人
发表于 2025-3-23 03:21:11
http://reply.papertrans.cn/29/2844/284375/284375_9.png
arrhythmic
发表于 2025-3-23 06:12:21
Lipid Nephrotoxicity: New Concept for an Old Disease,distribution and renal vascular injury, and also causes statin resistance. This concept alters traditional understanding of the pathogenesis of lipid-mediated renal and vascular injury, and evaluation of renal and cardiovascular risk and lipid-lowering treatment in such patients.